Sign in
DRTSW Stock Price, Chart, Stats & News
Alpha Tau Medical Ltd.
Save
891.04M
Market cap
–
Current P/E
–
Forward P/E
DRTSW chart
1M
3M
1Y
5Y
Loading chart...
Fundamentals
Gross margin | – |
Operating margin | – |
Pretax margin | – |
Net margin | – |
Effective tax rate | -0.32% |
ROA | -40.00% |
ROE | -57.29% |
D/E | 0.18x |
Interest coverage ratio | – |
DRTSW valuation
P/E | – |
P/S | – |
P/B | 7.62x |
P/CF | -22.03x |
P/FCF | -18.43x |
P/OCF | -22.03x |
PEG | -0.14x |
EV multiple | -14.59x |
About
Alpha Tau Medical Ltd. is a clinical-stage oncology therapeutics company, which focuses on the research, development, and commercialization of diffusing alpha-emitters radiation therapy for the treatment of cancer. The firm is involved in the clinical trials at cancer centers with indications that include skin cancer, oral cavity cancer, breast cancer, and pancreatic cancer. The company was founded by Uzi Sofer, Yona Keisari, and Itzhak Kelson in November 2015 and is headquartered in Jerusalem, Israel.
Similar securities
Based on sector and market capitalization
Report issue